Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
In Phase 3 of the TRIUMPH-4 clinical trial, Retatrutide, a triple hormone receptor agonist, produced substantial improvements in both body weight and osteoarthritis-related pain in adults with obesity
Combined revenue from those two products reached $12.8 billion in Q1 2026, representing $6.7 billion in year-over-year growth
Semaglutide GLP-1 for medical weight loss can be obtained through a prescription from a licensed healthcare provider, often at specialized weight loss clinics, endocrinology practices, or telemedicine services
Or it may turn out that most of the healthspan benefit comes from treating obesity and metabolic dysfunction extraordinarily well
US$ 26.44
US$ 26.03
US$ 24.99
US$ 21.42
US$ 20.39
US$ 25.99
US$ 28.80
